成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

返回ChemicalBook首頁>CAS數(shù)據庫列表>41733-55-5

41733-55-5

中文名稱 呋塞米鈉
英文名稱 sodium 5-(aminosulphonyl)-4-chloro-2-(furan-2-ylmethyl)anthranilate
CAS 41733-55-5
分子式 C12H11ClN2NaO5S
分子量 353.734
MOL 文件 41733-55-5.mol
更新日期 2023/03/20 15:41:23
41733-55-5 結構式 41733-55-5 結構式

基本信息

中文別名
呋塞米鈉
英文別名
Fursemide sodium
FuroseMide (sodiuM)
Sodium 5-(aminosulfonyl)-4-chloro-2-(furan-2-ylmethyl)anthranilate
sodium 5-(aminosulphonyl)-4-chloro-2-(furan-2-ylmethyl)anthranilate
5-(Aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino]benzoic acid sodium salt

物理化學性質

儲存條件-20°C儲存
溶解度DMSO: ≥ 150 mg/mL (425.25 mM)
形態(tài)Solid
顏色White to off-white
呋塞米鈉價格(試劑級)
報價日期產品編號產品名稱CAS號包裝價格
2024/11/08HY-B0135A呋塞米鈉
Furosemide sodium
41733-55-5500mg900元
2024/11/08HY-B0135A呋塞米鈉
Furosemide sodium
41733-55-510mM * 1mLin DMSO990元
2024/11/08HY-B0135A呋塞米鈉
Furosemide sodium
41733-55-51g1500元

常見問題列表

生物活性
Furosemide sodium 是 Na+/K+/2Cl-?(NKCC),NKCC1 和 NKCC2 共轉運蛋白的有效的和具有口服活性抑制劑。Furosemide sodium 也是 GABAA 受體拮抗劑,對含 α6 受體的選擇性是含 α1 受體的 100 倍。Furosemide sodium 用作利尿試劑,用于充血性心力衰竭,高血壓和水腫的研究。
靶點

IC50: NKCC1 and NKCC2IC50: GABA A receptors

體外研究

Furosemide sodium (500 μM; 72-96 hours) significantly changes the proliferation rates in MKN45 cells (the poorly differentiated human gastric adenocarcinoma cell line). however, it has no effects on MKN28 cells (the moderately differentiated human gastric adenocarcinoma cell line). The growth rate of MKN45 cells is larger than that of MKN28 cells.Furosemide sodium (10 μM, 30 μM, 100 μM; 45 min exposure)significantly decreases cation channel activity and [Ca(2+)](i) in human erythrocytes drawn from healthy individuals. Tert-butylhydroperoxide similarly enhances the non-selective cation channels activity, increases [Ca(2+)](i) and triggered cell membrane scrambling, however, the effects is significantly blunted by Furosemide sodium again.

體內研究

Furosemide sodium (intraperitoneal injection; 100 mg/kg; single dose) is injected after kanamycin (KM) (1000 mg/kg) to creat a deaf mouse model in C57BL/6 mouse. After injection, hearing loss and cochlear hair cell damage are evaluated on day 1, day 2 and day 3, respectively. The hearing is markedly deteriorated even from the next day (Day-1 group), OHCs (outer hair cell) morphology of apical, middle and basal turns are disorganized in mice on day3.

"41733-55-5" 相關產品信息